MGNX

SEC source: 0001125345-24-000038 · wk-form4_1708470257.xml · derivative · entry 3

Risser Eric Blasius · CIK 0001587774 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,330

Underlying: Common Stock · 16,670 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.exercise_date: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.expiration_date: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

SEC source: 0001125345-24-000038 · wk-form4_1708470257.xml · nonDerivative · entry 2

Risser Eric Blasius · CIK 0001587774 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,059

SEC source: 0001125345-24-000038 · wk-form4_1708470257.xml · nonDerivative · entry 1

Risser Eric Blasius · CIK 0001587774 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,938

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

SEC source: 0001125345-24-000037 · wk-form4_1708470239.xml · derivative · entry 3

Karrels James · CIK 0001587477 · SVP, CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,997

Underlying: Common Stock · 15,003 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 15, 2023 the reporting person was granted 45,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.exercise_date: On February 15, 2023 the reporting person was granted 45,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.expiration_date: On February 15, 2023 the reporting person was granted 45,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

SEC source: 0001125345-24-000037 · wk-form4_1708470239.xml · nonDerivative · entry 2

Karrels James · CIK 0001587477 · SVP, CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,452

F2 · ownership.direct: Owned jointly with reporting person's wife.

SEC source: 0001125345-24-000037 · wk-form4_1708470239.xml · nonDerivative · entry 1

Karrels James · CIK 0001587477 · SVP, CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 206,779

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 15, 2023 the reporting person was granted 45,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

SEC source: 0001125345-24-000036 · wk-form4_1708470220.xml · derivative · entry 3

Spitznagel Thomas · CIK 0001675464 · Sr VP, Technical Ops

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,664

Underlying: Common Stock · 13,336 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 15, 2023 the reporting person was granted 40,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.exercise_date: On February 15, 2023 the reporting person was granted 40,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.expiration_date: On February 15, 2023 the reporting person was granted 40,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

SEC source: 0001125345-24-000036 · wk-form4_1708470220.xml · nonDerivative · entry 2

Spitznagel Thomas · CIK 0001675464 · Sr VP, Technical Ops

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,316

SEC source: 0001125345-24-000036 · wk-form4_1708470220.xml · nonDerivative · entry 1

Spitznagel Thomas · CIK 0001675464 · Sr VP, Technical Ops

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,336

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 15, 2023 the reporting person was granted 40,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

SEC source: 0001125345-24-000035 · wk-form4_1708470190.xml · derivative · entry 3

Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,330

Underlying: Common Stock · 16,670 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.exercise_date: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.expiration_date: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

SEC source: 0001125345-24-000035 · wk-form4_1708470190.xml · nonDerivative · entry 2

Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,133

SEC source: 0001125345-24-000035 · wk-form4_1708470190.xml · nonDerivative · entry 1

Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,004

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

SEC source: 0001125345-24-000024 · wk-form4_1707777166.xml · derivative · entry 2

Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,000

Underlying: Common Stock · 17,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.expiration_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

SEC source: 0001125345-24-000024 · wk-form4_1707777166.xml · derivative · entry 1

Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2034-02-08

F1 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.

SEC source: 0001125345-24-000022 · wk-form4_1707777143.xml · derivative · entry 2

Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,500

Underlying: Common Stock · 33,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.expiration_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

SEC source: 0001125345-24-000022 · wk-form4_1707777143.xml · derivative · entry 1

Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2034-02-08

F1 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

SEC source: 0001125345-24-000023 · wk-form4_1707777154.xml · derivative · entry 2

Spitznagel Thomas · CIK 0001675464 · Sr VP, Technical Ops

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,000

Underlying: Common Stock · 27,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.expiration_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

SEC source: 0001125345-24-000023 · wk-form4_1707777154.xml · derivative · entry 1

Spitznagel Thomas · CIK 0001675464 · Sr VP, Technical Ops

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,000

Underlying: Common Stock · 71,000 shares

Expires 2034-02-08

F1 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.

SEC source: 0001125345-24-000021 · wk-form4_1707777132.xml · derivative · entry 2

Risser Eric Blasius · CIK 0001587774 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,500

Underlying: Common Stock · 33,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.expiration_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

SEC source: 0001125345-24-000021 · wk-form4_1707777132.xml · derivative · entry 1

Risser Eric Blasius · CIK 0001587774 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2034-02-08

F1 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.

SEC source: 0001125345-24-000020 · wk-form4_1707777115.xml · derivative · entry 2

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,000

Underlying: Common Stock · 27,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.expiration_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

SEC source: 0001125345-24-000020 · wk-form4_1707777115.xml · derivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,000

Underlying: Common Stock · 71,000 shares

Expires 2034-02-08

F1 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.

SEC source: 0001125345-24-000019 · wk-form4_1707777099.xml · derivative · entry 2

Koenig Scott · CIK 0001587514 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,000

Underlying: Common Stock · 95,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.expiration_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

SEC source: 0001125345-24-000019 · wk-form4_1707777099.xml · derivative · entry 1

Koenig Scott · CIK 0001587514 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 248,000

Underlying: Common Stock · 248,000 shares

Expires 2034-02-08

F1 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.

SEC source: 0001125345-24-000018 · wk-form4_1707777084.xml · derivative · entry 2

Karrels James · CIK 0001587477 · SVP, CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.expiration_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

SEC source: 0001125345-24-000018 · wk-form4_1707777084.xml · derivative · entry 1

Karrels James · CIK 0001587477 · SVP, CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2034-02-08

F1 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.

SEC source: 0001125345-24-000017 · wk-form4_1707777058.xml · derivative · entry 2

Eck Stephen L. · CIK 0001669041 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,500

Underlying: Common Stock · 33,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.expiration_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

SEC source: 0001125345-24-000017 · wk-form4_1707777058.xml · derivative · entry 1

Eck Stephen L. · CIK 0001669041 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2034-02-08

F1 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.

SEC source: 0001125345-24-000008 · wk-form4_1707340726.xml · nonDerivative · entry 1

Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,334

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2023.

SEC source: 0001125345-24-000007 · wk-form4_1707340620.xml · derivative · entry 6

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,125

Underlying: Common Stock · 21,875 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.

SEC source: 0001125345-24-000007 · wk-form4_1707340620.xml · derivative · entry 5

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,875

Underlying: Common Stock · 54,376 shares

Expires 2030-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.

SEC source: 0001125345-24-000007 · wk-form4_1707340620.xml · nonDerivative · entry 4

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/10/2022.

SEC source: 0001125345-24-000007 · wk-form4_1707340620.xml · nonDerivative · entry 3

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,875

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/10/2022.

SEC source: 0001125345-24-000007 · wk-form4_1707340620.xml · nonDerivative · entry 2

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 76,251

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001125345-24-000007 · wk-form4_1707340620.xml · nonDerivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,376

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001125345-24-000004 · wk-form4_1706908871.xml · nonDerivative · entry 1

Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,668

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2023.

SEC source: 0001125345-24-000002 · wk-form4_1705960631.xml · nonDerivative · entry 1

Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 87,984

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2023.

SEC source: 0001125345-23-000131 · wk-form4_1703193165.xml · nonDerivative · entry 1

Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 101,300

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2023

SEC source: 0000899243-23-019881 · doc4.xml · nonDerivative · entry 1

BIOTECH TARGET N V · CIK 0001259870 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,929,963

SEC source: 0000899243-23-018688 · doc4.xml · nonDerivative · entry 1

BIOTECH TARGET N V · CIK 0001259870 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,779,963

SEC source: 0001125345-23-000111 · wk-form4_1693598784.xml · nonDerivative · entry 1

HURWITZ EDWARD · CIK 0001211840 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,074

F1 · price: The price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $4.90 to $4.91. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

SEC source: 0001125345-23-000100 · wk-form4_1685739551.xml · derivative · entry 2

Ferrante Karen Jean · CIK 0001598502 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,500

Underlying: Common Stock · 4,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer?s Common Stock. The RSU grant was approved by the Issuer?s Board of Directors on May 31, 2023 and will be effective as of the date the Issuer has an effective Registration Statement on Form S-8 registering the shares available for issuance under the 2023 Equity Incentive Plan.

F3 · derivative.exercise_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier.

F3 · derivative.expiration_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier.

SEC source: 0001125345-23-000100 · wk-form4_1685739551.xml · derivative · entry 1

Ferrante Karen Jean · CIK 0001598502 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2033-05-31

F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

SEC source: 0001125345-23-000099 · wk-form4_1685739483.xml · derivative · entry 2

HURWITZ EDWARD · CIK 0001211840 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,500

Underlying: Common Stock · 4,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer?s Common Stock. The RSU grant was approved by the Issuer?s Board of Directors on May 31, 2023 and will be effective as of the date the Issuer has an effective Registration Statement on Form S-8 registering the shares available for issuance under the 2023 Equity Incentive Plan.

F3 · derivative.exercise_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

F3 · derivative.expiration_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

SEC source: 0001125345-23-000099 · wk-form4_1685739483.xml · derivative · entry 1

HURWITZ EDWARD · CIK 0001211840 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2033-05-31

F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

SEC source: 0001125345-23-000098 · wk-form4_1685739418.xml · derivative · entry 2

Jackson Scott Thomas · CIK 0001566617 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,500

Underlying: Common Stock · 4,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer?s Common Stock. The RSU grant was approved by the Issuer?s Board of Directors on May 31, 2023 and will be effective as of the date the Issuer has an effective Registration Statement on Form S-8 registering the shares available for issuance under the 2023 Equity Incentive Plan.

F3 · derivative.exercise_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

F3 · derivative.expiration_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

SEC source: 0001125345-23-000098 · wk-form4_1685739418.xml · derivative · entry 1

Jackson Scott Thomas · CIK 0001566617 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2033-05-31

F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

SEC source: 0001125345-23-000097 · wk-form4_1685739326.xml · derivative · entry 2

Liu Margaret · CIK 0001324059 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,500

Underlying: Common Stock · 4,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer?s Common Stock. The RSU grant was approved by the Issuer?s Board of Directors on May 31, 2023 and will be effective as of the date the Issuer has an effective Registration Statement on Form S-8 registering the shares available for issuance under the 2023 Equity Incentive Plan.

F3 · derivative.exercise_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

F3 · derivative.expiration_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

SEC source: 0001125345-23-000097 · wk-form4_1685739326.xml · derivative · entry 1

Liu Margaret · CIK 0001324059 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2033-05-31

F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

SEC source: 0001125345-23-000096 · wk-form4_1685739273.xml · derivative · entry 2

STUMP DAVID C · CIK 0001191235 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,500

Underlying: Common Stock · 4,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer?s Common Stock. The RSU grant was approved by the Issuer?s Board of Directors on May 31, 2023 and will be effective as of the date the Issuer has an effective Registration Statement on Form S-8 registering the shares available for issuance under the 2023 Equity Incentive Plan.

F3 · derivative.exercise_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

F3 · derivative.expiration_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier